RxDoctor Payments Data

Robert Blem, MD

Ophthalmology · Lafayette, LANPI 1528026838

Payments from drug & device makers

$1,424in general payments, 2019–2025

Across 29 payments — averaging $49.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dutch Ophthalmic, USA$266
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$264
  • Biotissue Holdings Inc.$240
  • Ocular Therapeutix, Inc.$132
  • Sun Pharmaceutical Industries Inc.$129
  • Regeneron Healthcare Solutions, Inc.$118
  • plus $275 from 7 others

What the payments were for

  • Food & beverage$1,424100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,424 in reported general payments places this provider in the 40th percentile of 286 ophthalmology providers in Louisiana.

See all ophthalmology providers in Louisiana

Medicare billing

Part B allowed, 2024
$1,686,363
Medicare patients
1,311
Services billed
8,794

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Restasis MultidoseCyclosporine15$9,305
Ketorolac Tromethamine344$8,341
Prednisolone Acetate300$7,809
CombiganBrimonidine Tartrate/Timolol20$4,014
Brimonidine Tartrate128$3,035
Alphagan PBrimonidine Tartrate11$2,388
Difluprednate13$1,252
Acetazolamide14$748
Latanoprost91$642
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat28$419
Timolol Maleate15$75
Prednisone15$59
Alprazolam81$58

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →